Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Australia's Starpharma, Ansell to supply anti-Zika condoms for Olympics

Published 05/15/2016, 09:33 PM
Updated 05/15/2016, 09:50 PM
© Reuters. File photo shows an Aedes aegypti mosquito inside a test tube as part of a research on preventing the spread of the Zika virus and other mosquito-borne diseases at a control and prevention center in Guadalupe, neighbouring Monterrey

SYDNEY (Reuters) - Australian pharmaceutical company Starpharma Holdings Ltd said it is teaming up with world No. 2 condom maker Ansell Ltd to supply Zika virus-proof condoms to the Australian Olympic team ahead of the 2016 Rio de Janeiro games.

Starpharma said it is giving the Australian athletes Ansell "Dual Protect" condoms lubricated with Starpharma's VivaGel product, which it recently said showed near-total antiviral protection against Zika and other viruses in laboratory studies.

"Given sexual transmission of Zika virus is of increasing importance, the potent activity of Starpharma's VivaGel against Zika could prove very significant," said Starpharma Chief Executive Officer Jackie Fairley in a statement.

The Australian Olympic Committee (AOC) said the Starpharma condoms would be in addition to condoms already shipped to the Olympic village, which will also have free dispensing machines on every block supplying 350,000 male condoms and 100,000 female condoms to athletes.

© Reuters. File photo shows an Aedes aegypti mosquito inside a test tube as part of a research on preventing the spread of the Zika virus and other mosquito-borne diseases at a control and prevention center in Guadalupe, neighbouring Monterrey

The AOC dismissed suggestions that athletes returning from Rio should undergo compulsory blood testing. People who follow the recommended precautions have a low risk of Zika and blanket testing "is not aligned with medical or scientific best practice," it said in a statement.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.